Olema Pharmaceuticals (OLMA)
US Market

Olema Pharmaceuticals (OLMA) Stock Price & Analysis


OLMA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.19 - $7.45
Previous Close$5.37
Average Volume (3M)181.85K
Market Cap
Enterprise Value$35.23M
Total Cash (Recent Filing)$185.95M
Total Debt (Recent Filing)$2.29M
Price to Earnings (P/E)-2.0
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.74
Shares Outstanding40,761,714
10 Day Avg. Volume191,563
30 Day Avg. Volume181,853
Standard Deviation0.31
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.31
Price Target Upside213.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Olema Pharmaceuticals’s price range in the past 12 months?
Olema Pharmaceuticals lowest stock price was $2.19 and its highest was $7.45 in the past 12 months.
    What is Olema Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Olema Pharmaceuticals’s upcoming earnings report date?
    Olema Pharmaceuticals’s upcoming earnings report date is Aug 08, 2023 which is in 68 days.
      How were Olema Pharmaceuticals’s earnings last quarter?
      Olema Pharmaceuticals released its earnings results on May 09, 2023. The company reported -$0.7 earnings per share for the quarter, missing the consensus estimate of -$0.663 by -$0.037.
        Is Olema Pharmaceuticals overvalued?
        According to Wall Street analysts Olema Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Olema Pharmaceuticals pay dividends?
          Olema Pharmaceuticals does not currently pay dividends.
          What is Olema Pharmaceuticals’s EPS estimate?
          Olema Pharmaceuticals’s EPS estimate is -$0.73.
            How many shares outstanding does Olema Pharmaceuticals have?
            Olema Pharmaceuticals has 40,761,715 shares outstanding.
              What happened to Olema Pharmaceuticals’s price movement after its last earnings report?
              Olema Pharmaceuticals reported an EPS of -$0.7 in its last earnings report, missing expectations of -$0.663. Following the earnings report the stock price went down -8.666%.
                Which hedge fund is a major shareholder of Olema Pharmaceuticals?
                Among the largest hedge funds holding Olema Pharmaceuticals’s share is Fairmount Funds Management Llc. It holds Olema Pharmaceuticals’s shares valued at N/A.


                  Olema Pharmaceuticals Stock Smart Score

                  The Olema Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Olema Pharmaceuticals

                  Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250.


                  Top 5 ETFs holding OLMA

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold OLMA. The ETFs are listed according to market value of OLMA within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  RAPT Therapeutics
                  Kala Pharmaceuticals
                  Mersana Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis